Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Prevalence and risk of migraine in patients with rosacea: A population-based cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Adverse reactions to tattoos in the general population of Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The chronobiology of migraine: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  2. PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Alexander Egeberg
  • Messoud Ashina
  • David Gaist
  • Gunnar H Gislason
  • Jacob P Thyssen
View graph of relations

BACKGROUND: Rosacea features increased neurovascular reactivity; migraine is a complex neurologic disorder characterized by recurrent episodes of headache associated with nausea and increased sensitivity to light and sound.

OBJECTIVE: We evaluated the prevalence and risk of new-onset migraine in patients with rosacea.

METHODS: All Danish individuals 18 years of age or older were linked in nationwide registers. Adjusted hazard ratios (HRs) were estimated by Cox regression.

RESULTS: In the total cohort (n = 4,361,688), there were 49,475 patients with rosacea. Baseline prevalence of migraine was 7.3% and 12.1% in the reference population and in patients with rosacea, respectively. The fully adjusted HR of migraine was 1.31 (95% confidence interval 1.23-1.39) for patients with rosacea. Patients with phymatous rosacea (n = 594) had no increased risk of migraine (adjusted HR 0.45; 95% confidence interval 0.11-1.80), whereas patients with ocular rosacea (n = 6977) had a 69% increased risk (adjusted HR 1.69; 95% confidence interval 1.43-1.99). Notably, the risk was higher among patients age 50 years or older than in younger individuals, and the risk was only significant among women.

LIMITATIONS: We were unable to distinguish between migraine subtypes.

CONCLUSION: We found a significantly higher prevalence and risk of incident migraine especially in female patients with rosacea. These data add to the accumulating evidence for a link between rosacea and the central nervous system.

Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume76
Issue number3
Pages (from-to)454-458
ISSN0190-9622
DOIs
Publication statusPublished - 2017

ID: 49270109